Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Sep-24 2:05 PM View:  | Bio-Rad Laboratories Inc. (BIO BIOB) | 06-Sep-24 | Option Exercise | 3,000 | $299.24 | $897,720.00 | 40% 7.56K to 10.56K | |
| 10-Sep-24 2:05 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 06-Sep-24 | Option Sale | 3,000 | $329.94 | $989,815.00 | (28%) 10.56K to 7.56K | |
| 04-Sep-24 8:19 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-24 | Payment of Exercise | 458 | $337.32 | $154,493.00 | (6%) 8.02K to 7.56K | |
| 04-Sep-24 8:19 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-24 | Option Exercise | 903 | -- | -- | 13% 7.11K to 8.02K | |
| 04-Sep-24 8:19 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-24 | Payment of Exercise | 1,396 | $337.32 | $470,899.00 | (16%) 8.51K to 7.11K | |
| 04-Sep-24 8:19 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-24 | Option Exercise | 2,752 | -- | -- | 48% 5.76K to 8.51K | |
| 30-Apr-24 5:53 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-24 | Payment of Exercise | 357 | $277.11 | $98,928.30 | (6%) 6.08K to 5.72K | |
| 30-Apr-24 5:53 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-24 | Option Exercise | 1,000 | -- | -- | 20% 5.08K to 6.08K | |
| 06-Sep-23 2:28 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-23 | Payment of Exercise | 448 | $394.60 | $176,781.00 | (8%) 5.49K to 5.04K | |
| 06-Sep-23 2:28 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-23 | Option Exercise | 903 | -- | -- | 20% 4.58K to 5.49K | |
| 06-Sep-23 2:28 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-23 | Payment of Exercise | 709 | $394.60 | $279,771.00 | (13%) 5.29K to 4.58K | |
| 06-Sep-23 2:28 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-23 | Option Exercise | 1,500 | -- | -- | 40% 3.79K to 5.29K | |
| 27-Jun-23 9:30 PM View: | Oncocyte Corp (OCX) | 23-Jun-23 | Grant | 20,000 | -- | -- | 29% 70.17K to 90.17K | |
| 01-May-23 12:51 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-23 | Payment of Exercise | 346 | $450.79 | $155,973.00 | (8%) 4.11K to 3.77K | |
| 01-May-23 12:51 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-23 | Option Exercise | 1,000 | -- | -- | 32% 3.11K to 4.11K | |
| 07-Sep-22 2:14 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-22 | Payment of Exercise | 448 | $478.32 | $214,287.00 | (13%) 3.53K to 3.08K | |
| 07-Sep-22 2:14 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 02-Sep-22 | Option Exercise | 902 | -- | -- | 34% 2.63K to 3.53K | |
| 06-Sep-22 1:56 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-22 | Payment of Exercise | 314 | $486.25 | $152,682.00 | (11%) 2.94K to 2.63K | |
| 06-Sep-22 1:56 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 01-Sep-22 | Option Exercise | 633 | -- | -- | 27% 2.31K to 2.94K | |
| 19-Aug-22 8:00 AM View: | Oncocyte Corp (OCX) | 17-Aug-22 | Private Purchase | 20,000 | $0.87 | $17,400.00 | 40% 50.17K to 70.17K | |
| 17-Aug-22 8:21 PM View: | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 25% 40.17K to 50.17K | |
| 19-Jul-22 4:05 PM View: | Oncocyte Corp (OCX) | 24-Jun-22 | Option Exercise | 10,000 | -- | -- | 33% 30.17K to 40.17K | |
| 02-May-22 2:44 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-22 | Payment of Exercise | 471 | $512.06 | $241,180.00 | (17%) 2.76K to 2.29K | |
| 02-May-22 2:44 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-22 | Option Exercise | 1,000 | -- | -- | 57% 1.76K to 2.76K | |
| 14-Jun-21 8:20 PM View: | Oncocyte Corp (OCX) | 11-Jun-21 | Exercise (in-the money or at-the-money) | 6,993 | $3.00 | $20,979.00 | 30% 23.18K to 30.17K | |
| 30-Apr-21 2:31 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-21 | Payment of Exercise | 466 | $640.73 | $298,580.00 | (27%) 1.73K to 1.27K | |
| 30-Apr-21 2:31 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-21 | Option Exercise | 1,000 | -- | -- | 136% 0.73K to 1.73K | |
| 15-Dec-20 6:27 AM View: | Oncocyte Corp (OCX) | 11-Dec-20 | Grant | 16,184 | -- | -- | 231% 6.99K to 23.18K | |
| 30-Apr-20 2:14 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-20 | Payment of Exercise | 346 | $436.27 | $150,949.00 | (34%) 1.03K to 0.68K | |
| 30-Apr-20 2:14 PM View: | Bio-Rad Laboratories Inc. (BIO BIOB) | 29-Apr-20 | Option Exercise | 1,000 | -- | -- | 3846% 26 to 1.03K | |
| 31-Jul-18 9:38 PM View: | Oncocyte Corp (OCX) | 26-Jul-18 | Purchase | 6,993 | -- | -- | 100% 0 to 6.99K | |
| 15-Nov-17 4:17 PM View: | Precigen, Inc. (PGEN) | 13-Nov-17 | Market Purchase | 2,000 | $12.10 | $24,200.00 | 100% 2.0K to 4.0K | 54% |
| 15-Aug-17 1:14 PM View: | Precigen, Inc. (PGEN) | 14-Aug-17 | Market Purchase | 2,000 | $19.99 | $39,980.00 | 100% 0 to 2.0K | (7%) |
| 01-Apr-16 5:37 PM View: | Affymetrix Inc. (AFFX) | 31-Mar-16 | Disposition | 223,548 | -- | -- | (100%) 223.55K to 0 | |
| 25-Feb-16 7:44 PM View: | Affymetrix Inc. (AFFX) | 25-Feb-16 | Payment of Exercise | 940 | $14.06 | $13,216.40 | (< 1%) 224.49K to 223.55K | < 1% |
| 22-Feb-16 7:00 PM View: | Affymetrix Inc. (AFFX) | 19-Feb-16 | Payment of Exercise | 6,271 | $13.98 | $87,668.60 | (1%) 456.85K to 450.57K | (< 1%) |
| 22-Feb-16 7:00 PM View: | Affymetrix Inc. (AFFX) | 18-Feb-16 | Grant | 35,817 | -- | -- | 9% 421.03K to 456.85K | |
| 17-Feb-16 4:28 PM View: | Affymetrix Inc. (AFFX) | 14-Feb-16 | Payment of Exercise | 2,819 | $14.09 | $39,719.70 | (1%) 197.76K to 194.94K | < 1% |
| 17-Feb-16 4:28 PM View: | Affymetrix Inc. (AFFX) | 13-Feb-16 | Payment of Exercise | 9,648 | $14.09 | $135,940.00 | (5%) 207.41K to 197.76K | < 1% |
| 10-Feb-16 10:00 PM View: | Affymetrix Inc. (AFFX) | 08-Feb-16 | Grant | 37,297 | -- | -- | 22% 170.11K to 207.41K | |
| 26-Mar-15 6:53 PM View: | Affymetrix Inc. (AFFX) | 25-Mar-15 | Option Exercise | 110,000 | $5.10 | $560,500.00 | 65% 170.11K to 280.11K | |
| 26-Mar-15 6:53 PM View: | Affymetrix Inc. (AFFX) | 25-Mar-15 | Market Option Sale (Planned) | 110,000 | $12.79 | $1,406,900.00 | (39%) 280.11K to 170.11K | 6% |
| 26-Feb-15 8:14 PM View: | Affymetrix Inc. (AFFX) | 25-Feb-15 | Payment of Exercise | 5,638 | $11.64 | $65,626.30 | (3%) 175.75K to 170.11K | (3%) |
| 19-Feb-15 7:23 PM View: | Affymetrix Inc. (AFFX) | 19-Feb-15 | Grant | 17,000 | -- | -- | 11% 158.75K to 175.75K | |
| 18-Feb-15 4:39 PM View: | Affymetrix Inc. (AFFX) | 17-Feb-15 | Payment of Exercise | 940 | $11.77 | $11,063.80 | (< 1%) 159.69K to 158.75K | (2%) |
| 18-Feb-15 4:39 PM View: | Affymetrix Inc. (AFFX) | 14-Feb-15 | Payment of Exercise | 2,837 | $11.45 | $32,483.70 | (2%) 162.53K to 159.69K | (5%) |
| 18-Feb-15 4:39 PM View: | Affymetrix Inc. (AFFX) | 13-Feb-15 | Payment of Exercise | 9,699 | $11.45 | $111,054.00 | (6%) 172.23K to 162.53K | (5%) |
| 04-Feb-15 6:28 PM View: | Affymetrix Inc. (AFFX) | 02-Feb-15 | Grant | 40,000 | -- | -- | 30% 132.23K to 172.23K | |
| 21-Aug-14 4:23 PM View: | Affymetrix Inc. (AFFX) | 19-Aug-14 | Payment of Exercise | 1,410 | $8.73 | $12,309.30 | (1%) 133.64K to 132.23K | (37%) |
| 27-Feb-14 5:36 PM View: | Affymetrix Inc. (AFFX) | 25-Feb-14 | Payment of Exercise | 5,554 | $7.47 | $41,488.40 | (4%) 139.19K to 133.64K | (60%) |